Close this search box.

We are creating some awesome events for you. Kindly bear with us.

PolyU’s Policy Paper for Unlocking Innovation 

Getting your Trinity Audio player ready...

The Policy Research Centre for Innovation and Technology (PReCIT) and the Research Centre for Chinese Medicine Innovation (RCMI) at The Hong Kong Polytechnic University (PolyU) have collaborated on a policy paper that outlines recommendations to policymakers for capitalising on the opportunities arising from the dynamic consumer market and talent pool in the Greater Bay Area (GBA) with the aim of fostering the development and innovation in the traditional Chinese Medicine (CM) industry.

One of the primary focal points of the paper involves addressing the fragmented and limited funding mechanisms that have acted as impediments to the full realisation of the CM industry’s potential. The authors advise the Hong Kong Special Administrative Region (HKSAR) Government to cultivate a supportive and robust environment for the CM ecosystem.

This can be achieved by broadening the funding scope of the Chinese Medicine Development Fund and promoting collaboration between academia and industry, emphasising interdisciplinary approaches within CM research. The establishment of a research platform fund specifically tailored for industry-centric R&D projects is also recommended, as it would facilitate the more effective and widespread application of complementary and integrative CM-related healthcare solutions.

Furthermore, the authors advocate for the creation of a central research platform that comprises an Evidence-based Chinese Medicine Research Centre, in partnership with the Schools of Chinese Medicine in three local universities and CM hospitals nationwide. Additionally, an International Dietary Supplement and Botanical Drug Research Centre is encouraged to validate the efficacy and safety of CM, promoting both mental and physical wellness.

The paper underscores the importance of facilitating the export of the high-quality Lingnan CM brand to international markets. To achieve this, it recommends expediting the approval and mutual certification mechanisms of Chinese proprietary medicine among GBA cities, incentivising cross-boundary collaborations for research and development, streamlining evaluation processes, and aligning CM standards with international norms by progressively integrating them into the global regulatory framework.

Recognising the evolving needs across various sectors and the advancements in technology, the authors encourage the HKSAR Government to establish a three-way trading and cross-border cooperative blockchain platform designed for electronic contracting, circulation, and traceability procedures in CM projects. Additionally, the paper suggests placing a greater emphasis on branding and promoting CM-based Health Maintenance Products and functional food to meet the growing demand from an aging population.

In response to anticipated clinical staff shortages and evolving therapeutic demands, the paper urges the HKSAR Government to provide support for the adoption of cutting-edge technology. This includes the incorporation of sensors, the Internet of Things, and artificial intelligence in CM diagnosis, treatment, and monitoring.

Furthermore, the authors emphasise the pivotal role of talent in driving innovation. They recommend that the Government extend financial support to collaborative training programs organised by tertiary institutions in the GBA and CM hospitals in Hong Kong and Mainland China. This investment would nurture skilled CM talents poised to leverage the emerging opportunities within the GBA’s development.

The paper also highlights PolyU’s commitment to advancing CM research and application through interdisciplinary research efforts. It underscores the potential for Hong Kong to serve as a bridgehead for CM in the international arena, capitalising on the synergy between industry and academia. PolyU, with its strengths in interdisciplinary research, remains dedicated to contributing to the evolution of CM treatment and practices.

The Policy Research Centre for Innovation and Technology (PReCIT) and the Research Centre for Chinese Medicine Innovation (RCMI) at The Hong Kong Polytechnic University (PolyU) have collaboratively authored a comprehensive policy paper. This paper provides recommendations to policymakers aimed at stimulating innovation and development within the Chinese Medicine (CM) industry, particularly within the Greater Bay Area (GBA).

By addressing funding challenges, promoting internationalisation, encouraging commercialisation and innovation, and leveraging technology, these recommendations pave the way for a promising future for CM in Hong Kong and beyond. PolyU remains committed to its role in fostering CM research and application through interdisciplinary collaboration and research excellence.


Qlik’s vision is a data-literate world, where everyone can use data and analytics to improve decision-making and solve their most challenging problems. A private company, Qlik offers real-time data integration and analytics solutions, powered by Qlik Cloud, to close the gaps between data, insights and action. By transforming data into Active Intelligence, businesses can drive better decisions, improve revenue and profitability, and optimize customer relationships. Qlik serves more than 38,000 active customers in over 100 countries.


As a Titanium Black Partner of Dell Technologies, CTC Global Singapore boasts unparalleled access to resources.

Established in 1972, we bring 52 years of experience to the table, solidifying our position as a leading IT solutions provider in Singapore. With over 300 qualified IT professionals, we are dedicated to delivering integrated solutions that empower your organization in key areas such as Automation & AI, Cyber Security, App Modernization & Data Analytics, Enterprise Cloud Infrastructure, Workplace Modernization and Professional Services.

Renowned for our consulting expertise and delivering expert IT solutions, CTC Global Singapore has become the preferred IT outsourcing partner for businesses across Singapore.


Planview has one mission: to build the future of connected work. Our solutions enable organizations to connect the business from ideas to impact, empowering companies to accelerate the achievement of what matters most. Planview’s full spectrum of Portfolio Management and Work Management solutions creates an organizational focus on the strategic outcomes that matter and empowers teams to deliver their best work, no matter how they work. The comprehensive Planview platform and enterprise success model enables customers to deliver innovative, competitive products, services, and customer experiences. Headquartered in Austin, Texas, with locations around the world, Planview has more than 1,300 employees supporting 4,500 customers and 2.6 million users worldwide. For more information, visit


SIRIM is a premier industrial research and technology organisation in Malaysia, wholly-owned by the Minister​ of Finance Incorporated. With over forty years of experience and expertise, SIRIM is mandated as the machinery for research and technology development, and the national champion of quality. SIRIM has always played a major role in the development of the country’s private sector. By tapping into our expertise and knowledge base, we focus on developing new technologies and improvements in the manufacturing, technology and services sectors. We nurture Small Medium Enterprises (SME) growth with solutions for technology penetration and upgrading, making it an ideal technology partner for SMEs.


HashiCorp provides infrastructure automation software for multi-cloud environments, enabling enterprises to unlock a common cloud operating model to provision, secure, connect, and run any application on any infrastructure. HashiCorp tools allow organizations to deliver applications faster by helping enterprises transition from manual processes and ITIL practices to self-service automation and DevOps practices. 


IBM is a leading global hybrid cloud and AI, and business services provider. We help clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries. Nearly 3,000 government and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on IBM’s hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly, efficiently and securely. IBM’s breakthrough innovations in AI, quantum computing, industry-specific cloud solutions and business services deliver open and flexible options to our clients. All of this is backed by IBM’s legendary commitment to trust, transparency, responsibility, inclusivity and service.